Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca B Riggins

Showing results (51-60 of 73) with videos related to

Pageof 8
Sort By:
The Journal of Steroid Biochemistry and Molecular Biology|May 16, 2009
Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cellsRobert Clarke, Ayesha N Shajahan, Rebecca B Riggins, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2007
Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell linesBianca P Gomez, Rebecca B Riggins, Ayesha N Shajahan, et al.
Oncotarget|December 2, 2017
Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine methodHenri Wathieu, Naiem T Issa, Aileen I Fernandez, et al.
Bio-Protocol|December 19, 2017
RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer CellsYong-Wei Zhang, Rochelle E Nasto, Sandra A Jablonski, et al.
Methods in Enzymology|March 18, 2020
RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attackYong-Wei Zhang, Rochelle E Nasto, Sandra A Jablonski, et al.
Oncotarget|July 1, 2016
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancerMary M Heckler, Tizita Zewde Zeleke, Shailaja D Divekar, et al.
Breast Cancer Research and Treatment|November 20, 2019
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancerAileen I Fernandez, Xue Geng, Krysta Chaldekas, et al.
Cancer Research|November 1, 2008
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancerRebecca B Riggins, Jennifer P-J Lan, Yuelin Zhu, et al.
Molecular and Cellular Endocrinology|September 23, 2017
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilitiesHillary Stires, Mary M Heckler, Xiaoyong Fu, et al.
Pageof 8

Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
The Journal of Steroid Biochemistry and Molecular Biology|May 16, 2009
Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cellsRobert Clarke, Ayesha N Shajahan, Rebecca B Riggins, et al.
Biorxiv : the Preprint Server for Biology|September 4, 2023
Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast CancerShaymaa Bahnassy, Hillary Stires, Lu Jin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 31, 2007
Human X-box binding protein-1 confers both estrogen independence and antiestrogen resistance in breast cancer cell linesBianca P Gomez, Rebecca B Riggins, Ayesha N Shajahan, et al.
Oncotarget|December 2, 2017
Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine methodHenri Wathieu, Naiem T Issa, Aileen I Fernandez, et al.
Bio-Protocol|December 19, 2017
RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer CellsYong-Wei Zhang, Rochelle E Nasto, Sandra A Jablonski, et al.
Methods in Enzymology|March 18, 2020
RNA interference screening methods to identify proliferation determinants and mechanisms of resistance to immune attackYong-Wei Zhang, Rochelle E Nasto, Sandra A Jablonski, et al.
Oncotarget|July 1, 2016
Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancerMary M Heckler, Tizita Zewde Zeleke, Shailaja D Divekar, et al.
Breast Cancer Research and Treatment|November 20, 2019
The orphan nuclear receptor estrogen-related receptor beta (ERRβ) in triple-negative breast cancerAileen I Fernandez, Xue Geng, Krysta Chaldekas, et al.
Cancer Research|November 1, 2008
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancerRebecca B Riggins, Jennifer P-J Lan, Yuelin Zhu, et al.
Molecular and Cellular Endocrinology|September 23, 2017
Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilitiesHillary Stires, Mary M Heckler, Xiaoyong Fu, et al.
Pageof 8